Although in some cancer types such as endometrial and colorectal cancers, high PAI-2 expression was associated with poor prognosis [22,23], high PAI-2 expression was also shown to be correlated with better prognosis in breast and ovarian cancer [24,25]. Here, SERPINB2 is linked to ovarian carcinoma.